Stacey Silverman, a 55-year-old diagnosed with Type 1 diabetes at 48, relies on the insulin medication Levemir to manage her condition effectively. However, her health stability is now under threat as Novo Nordisk, the pharmaceutical company producing Levemir, has announced its discontinuation this year. This decision has left Silverman and thousands of patients in a … Read more